GINMU >

ブラウズ : 著者 Okura, Yasushi

発行日	タイトル	著者
2019年10月	Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase-4 inhibitor on hepatic fibrosis.	Shimozato, Naotaka; Namisaki, Tadashi; Kaji, Kosuke; Kitade, Mitsuteru; Okura, Yasushi; Sato, Shinya; Moriya, Kei; Seki, Kenichiro; Kawaratani, Hideto; Takaya, Hiroaki; Sawada, Yasuhiko; Saikawa, Soichiro; Nakanishi, Keisuke; Furukawa, Masanori; Fujinaga, Yukihisa; Kubo, Takuya; Asada, Kiyoshi; Kitagawa, Koh; Tsuji, Yuki; Kaya, Daisuke; Ozutsumi, Takahiro; Akahane, Takemi; Mitoro, Akira; Yoshiji, Hitoshi
2016年12月28日	Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis.	Okura, Yasushi; Namisaki, Tadashi; Moriya, Kei; Kitade, Mitsuteru; Takeda, Kosuke; Kaji, Kosuke; Noguchi, Ryuichi; Nishimura, Norihisa; Seki, Kenichiro; Kawaratani, Hideto; Takaya, Hiroaki; Sato, Shinya; Sawada, Yasuhiko; Shimozato, Naotaka; Furukawa, Masanori; Nakanishi, Keisuke; Saikawa, Soichiro; Kubo, Takuya; Asada, Kiyoshi; Yoshiji, Hitoshi
2019年3月	Combining probiotics and an angiotensin-II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non-alcoholic steatohepatitis.	Sawada, Yasuhiko; Kawaratani, Hideto; Kubo, Takuya; Fujinaga, Yukihisa; Furukawa, Masanori; Saikawa, Soichiro; Sato, Shinya; Seki, Kenichiro; Takaya, Hiroaki; Okura, Yasushi; Kaji, Kosuke; Shimozato, Naotaka; Mashitani, Tsuyoshi; Kitade, Mitsuteru; Moriya, Kei; Namisaki, Tadashi; Akahane, Takemi; Mitoro, Akira; Yamao, Junichi; Yoshiji, Hitoshi
2016年12月	Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long-Evans Tokushima fatty rats.	Nishimura, Norihisa; Kitade, Mitsuteru; Noguchi, Ryuichi; Namisaki, Tadashi; Moriya, Kei; Takeda, Kosuke; Okura, Yasushi; Aihara, Yosuke; Douhara, Akitoshi; Kawaratani, Hideto; Asada, Kiyoshi; Yoshiji, Hitoshi
2018年6月19日	Oral administration of fructose exacerbates liver fibrosis and hepatocarcinogenesis via increased intestinal permeability in a rat steatohepatitis model.	Seki, Kenichiro; Kitade, Mitsuteru; Nishimura, Norihisa; Kaji, Kosuke; Asada, Kiyoshi; Namisaki, Tadashi; Moriya, Kei; Kawaratani, Hideto; Okura, Yasushi; Takaya, Hiroaki; Sawada, Yasuhiko; Sato, Shinya; Nakanishi, Keisuke; Yoshiji, Hitoshi
2017年11月	Periostin cross‑reacts with the renin‑angiotensin system during liver fibrosis development.	Takeda, Kosuke; Noguchi, Ryuichi; Kitade, Mitsuteru; Namisaki, Tadashi; Moriya, Kei; Kawaratani, Hideto; Okura, Yasushi; Kaji, Kosuke; Aihara, Yosuke; Douhara, Akitoshi; Nishimura, Norihisa; Sawada, Yasuhiko; Seki, Kenichiro; Yoshiji, Hitoshi
2015年3月	Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model.	Douhara, Akitoshi; Moriya, Kei; Yoshiji, Hitoshi; Noguchi, Ryuichi; Namisaki, Tadashi; Kitade, Mitsuteru; Kaji, Kosuke; Aihara, Yosuke; Nishimura, Norihisa; Takeda, Kosuke; Okura, Yasushi; Kawaratani, Hideto; Fukui, Hiroshi
2018年12月	Sulforaphane Inhibits Liver Cancer Cell Growth and Angiogenesis.	Sato, Shinya; Moriya, Kei; Furukawa, Masanori; Saikawa, Soichiro; Namisaki, Tadashi; Kitade, Mitsuteru; Kawaratani, Hideto; Kaji, Kosuke; Takaya, Hiroaki; Shimozato, Naotaka; Sawada, Yasuhiko; Seki, Kenichiro; Kitagawa, Kou; Akahane, Takemi; Mitoro, Akira; Okura, Yasushi; Yoshiji, Hitoshi; Yamao, Junichi